Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2677 |
|
| Actual shortage: | 255 (10%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2413 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
30 (12%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-OXYCOCET | 5MG 325MG | TABLET | Resolved | 2020-07-16 | 2020-09-25 | 120453 |
| TEVA-OXYCOCET | 5MG 325MG | TABLET | Resolved | 2021-01-07 | 2021-02-05 | 131078 |
| TEVA-OXYCOCET | 5MG 325MG | TABLET | Resolved | 2021-03-25 | 2021-04-08 | 136304 |
| TEVA-OXYCODAN | 5MG 325MG | TABLET | Resolved | 2022-03-04 | 2022-03-09 | 156067 |
| TEVA-CILAZAPRIL/HCTZ | 5MG 12.5MG | TABLET | Resolved | 2020-10-22 | 2021-04-29 | 126948 |
| TEVA-LIOTHYRONINE | 5MCG | TABLET | Resolved | 2021-06-10 | 2021-07-09 | 140684 |
| TEVA-LIOTHYRONINE | 5MCG | TABLET | Resolved | 2021-12-02 | 2022-01-20 | 150400 |
| AERMONY RESPICLICK | 55MCG | POWDER (METERED DOSE) | Resolved | 2022-12-01 | 2023-01-18 | 176791 |
| TEVA-NAPROXEN SODIUM DS | 550MG | TABLET | Resolved | 2020-04-03 | 2020-04-09 | 110752 |
| TEVA-NAPROXEN SODIUM DS | 550MG | TABLET | Resolved | 2020-06-25 | 2020-07-23 | 118954 |
| TEVA-NAPROXEN SODIUM DS | 550MG | TABLET | Resolved | 2021-01-22 | 2021-03-18 | 132257 |
| TEVA-NAPROXEN SODIUM DS | 550MG | TABLET | Resolved | 2022-05-05 | 2022-06-04 | 160072 |
| TEVA-NAPROXEN SODIUM DS | 550MG | TABLET | Resolved | 2023-10-19 | 2023-11-09 | 207509 |
| TEVA-METHYLPHENIDATE ER-C | 54MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2017-11-24 | 2020-01-21 | 30691 |
| ACT METHYLPHENIDATE ER | 54MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-11-01 | 2024-02-13 | 65999 |
| NOVO-HYDROXYZIN | 50MG | CAPSULE | Actual shortage | 2017-03-13 | 2020-02-13 | 1017 |
| TEVA-QUETIAPINE XR | 50MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-03-13 | 2017-10-10 | 1778 |
| TEVA-ATENOLOL | 50MG | TABLET | Resolved | 2017-03-13 | 2020-02-13 | 1797 |
| TEVA-AMITRIPTYLINE | 50MG | TABLET | Resolved | 2017-03-14 | 2017-05-23 | 2434 |
| TEVA-AMITRIPTYLINE | 50MG | TABLET | Resolved | 2017-03-14 | 2017-05-23 | 2437 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| CLOXACILLIN SODIUM FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14018 |
| GEMCITABINE FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14033 |
| CEFTRIAXONE SODIUM FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2021-02-12 | 2021-02-12 | 133886 |
| ACT DILTIAZEM CD | 180MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2019-04-11 | 2019-04-11 | 81418 |
| TEVA-DILTIAZEM CD | 180MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2019-06-04 | 2019-06-04 | 85572 |
| ACT DILTIAZEM T | 180MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-05-14 | 2020-05-14 | 115120 |
| ACT DILTIAZEM CD | 180MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2021-07-22 | 2021-07-22 | 142921 |
| TEVA-ENALAPRIL | 16MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64866 |
| TEVA-PIOGLITAZONE | 15MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65026 |
| TEVA-RANITIDINE SOLUTION | 15MG | SOLUTION | Discontinued | 2019-04-11 | 2019-04-11 | 81304 |
| TEVA-ARIPIPRAZOLE | 15MG | TABLET | Discontinued | 2019-10-25 | 2019-10-26 | 97264 |
| ACT OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-01-24 | 2020-01-24 | 104277 |
| TEVA-ARIPIPRAZOLE | 15MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117538 |
| ACT RANITIDINE | 150MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115079 |
| TEVA-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-09-24 | 2020-09-24 | 124899 |
| TEVA-RISEDRONATE | 150MG | TABLET | Discontinued | 2021-02-12 | 2021-02-12 | 133905 |
| ACT VENLAFAXINE XR | 150.0MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65305 |
| NOVAMOXIN | 125MG | TABLET (CHEWABLE) | Discontinued | 2019-04-11 | 2019-04-11 | 81321 |
| TEVA-DIVALPROEX | 125MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-10-25 | 2019-10-26 | 97232 |
| NOVAMOXIN | 125MG | TABLET (CHEWABLE) | Discontinued | 2019-10-25 | 2019-10-26 | 97251 |